Maria Dalamaga | Clinical Chemistry | Best Medical Scientist Award

Prof. Dr. Maria Dalamaga | Clinical Chemistry | Best Medical Scientist Award

Professor Physician | National and Kapodistrian University of Athens | Greece

Dr. Maria Dalamaga is a distinguished researcher in Clinical Biochemistry and Laboratory Medicine, with a sustained record of high-impact contributions spanning metabolic disorders, inflammation, obesity-related cancers, endocrinology, and cardiometabolic diseases. Her work integrates molecular mechanisms, biomarker discovery, and translational research to advance evidence-based diagnostics and clinical decision-making. She has authored 227 peer-reviewed documents, demonstrating consistent leadership as first, senior, and corresponding author in internationally indexed journals. Her research output has garnered 8,899 citations, reflecting strong global influence and scientific relevance across multiple disciplines. With an h-index of 45, her scholarship is characterized by depth, continuity, and sustained impact. She has contributed to numerous competitive national and international research programs, supported interdisciplinary collaborations, and shaped research directions through editorial leadership in high-profile scientific journals. Overall, her research portfolio exemplifies excellence in productivity, citation impact, and translational significance within contemporary laboratory medicine and clinical biochemistry.

Citation Metrics (Scopus)

9000

6750

4000

2250

0

 

8,899
Citations

227
Documents

45
h-index

Citations

Documents

h-index

Featured Publications

Craig Rogers | Clinical Chemistry | Research Excellence Award

Dr. Craig Rogers | Clinical Chemistry | Research Excellence Award

Doctor | Henry Ford Health | United States

Dr. Craig G. Rogers, MD, FACS, is a globally recognized leader in urologic oncology and robotic surgery, with a distinguished academic record of 334 peer-reviewed publications, 11,699 citations, and an h-index of 55. His research has substantiallyadvanced robotic partial nephrectomy, cytoreductive nephrectomy, prostate cancer surgery, and minimally invasive management of complex renal and adrenal tumors. A key contributor to major multi-institutional collaborations such as the Vattikuti Collective Quality Initiative and the Michigan Urological Surgery Improvement Collaborative (MUSIC), Dr. Rogers has generated high-impact evidence on surgical quality, renal functional preservation, predictive modeling, and perioperative optimization. His work integrates machine learning, real-world registry data, multicenter outcomes, and translational oncology to refine prognostication in kidney and prostate cancers. He has also led and contributed to clinical trials in renal cell carcinoma, prostate cancer immunotherapy, and BCG optimization. Through scientific leadership, guideline development, editorial service, and education, Dr. Rogers continues to shape international standards in urologic cancer care.

Citation Metrics (Scopus)

12000
9000
6000
3000
0

11,699
Citations

334
Documents

55
h-index

Citations

Documents

h-index

Featured Publications

Hisae Aoshima | Clinical Chemistry | Best Researcher Award

Dr. Hisae Aoshima | Clinical Chemistry | Best Researcher Award

Manager at Mitsubishi Corporation Life Sciences Limited, Japan

Dr. Hisae Aoshima is an accomplished researcher in the field of cosmetic science with over two decades of dedicated work in fullerene-related research and its applications in dermatology. She is currently serving as the Manager of the Research and Development Group in the Cosmetic Division at Mitsubishi Corporation Life Sciences Ltd., following the integration of Vitamin C60 BioResearch Corporation into the company in April 2024. Her expertise has significantly contributed to the development of innovative cosmetic ingredients, notably Repista, a novel compound introduced under her leadership. Renowned for her technical acumen and pioneering spirit, Dr. Aoshima has gained international recognition for her research presentations and scientific publications.

profile

scopus

Education

Dr. Aoshima’s academic credentials reflect a deep commitment to interdisciplinary scientific exploration. She earned her second doctoral degree, a Doctor of Agriculture, from Shizuoka University in 2025, focused on the biological and dermatological efficacy of Repista. Prior to this, she received her first doctorate, a Doctor of Engineering, in 2010 from Nagaoka Technical University, where she concentrated on fullerene chemistry. Her graduate studies began with a Master of Science in 1999, following a Bachelor of Science in 1997, both from the same university, establishing her strong foundational knowledge in scientific research and material science.

Experience

With approximately 20 years of professional experience in the cosmetic and chemical research industry, Dr. Aoshima has held key positions contributing to product innovation and research strategy. Her career began in a private contract research firm as a researcher, where she honed her laboratory and project management skills. She then advanced to a managerial role at Vitamin C60 BioResearch Corporation, a company known for its pioneering work with fullerenes. Since the company’s merger into Mitsubishi Corporation Life Sciences Ltd., she has continued to lead R&D efforts, focusing on the cosmetic division. Her role involves supervising research projects, formulating active cosmetic ingredients, and translating complex chemical innovations into market-ready applications.

Research Interest

Dr. Aoshima’s research interests center on fullerene chemistry, dermatological applications of nanomaterials, and the development of bioactive cosmetic ingredients. Her work investigates the antioxidant and anti-inflammatory effects of fullerenes in skin health, as well as their integration into skincare formulations. Her most notable research revolves around Repista, a unique fullerene derivative that offers promising anti-aging and skin-regenerative benefits. She is also passionate about bridging the gap between bioengineering and consumer product science, contributing to the advancement of aesthetic dermatology through safe, science-backed innovations.

Award

Throughout her career, Dr. Aoshima has received multiple accolades for her groundbreaking work. Most notably, she was honored with the Best Presentation Award at the 39th Annual Meeting of the Japanese Society of Aesthetic Dermatology in 2021 for her study on Repista’s skin benefits. This recognition underscored her ability to convey complex scientific findings in a compelling and applicable manner. Additionally, her consistent contributions to cosmetic science have positioned her as a respected voice within various professional societies, where she actively participates in academic and industry dialogues.

Publication

Dr. Aoshima has authored 38 peer-reviewed academic papers, with 13 of them as the first author, showcasing her extensive contribution to scientific literature. Noteworthy among these are:

“Protective Effects of Repista on Skin Aging” (Journal of Cosmetic Dermatology, 2024, cited by 18 articles),

“Antioxidative Behavior of Fullerene Derivatives in Human Skin Cells” (Materials Science in Medicine, 2022, cited by 25 articles),

“Synergistic Effects of Fullerene and Vitamin C in Cosmetic Applications” (International Journal of Cosmetic Science, 2020, cited by 31 articles),

“Fullerene Stability and Delivery Mechanisms in Skin Cream Formulations” (Colloid Interface Science Reports, 2018, cited by 22 articles),

“Fullerene-Enhanced Sunscreen Agents” (Dermatological Science Reviews, 2016, cited by 16 articles),

“Nano-Antioxidants in Anti-Aging Therapies” (Advanced Cosmetic Technology, 2014, cited by 29 articles),

“Evaluation of Fullerene-Infused Serums in Long-Term Skin Application” (Journal of Aesthetic Science, 2012, cited by 20 articles).

Conclusion

With an exceptional blend of academic achievement, innovation-driven research, practical application in cosmetic science, and recognized leadership in fullerene and Repista-based product development, Dr. Hisae Aoshima exemplifies the qualities deserving of the Best Researcher Award. Her deep interdisciplinary knowledge, commitment to advancing cosmetic bioengineering, and recognized industry impact make her a model candidate whose contributions continue to shape the future of dermatological and anti-aging science.